CD90 liver cancer cells modulate endothelial cell phenotype through the release of exosomes containing H19 lncRNA priligy equivalent Our data provide a framework for exploring the molecular mechanisms that control enteric neurogenesis in vivo and identify glial cells as a potential target for cell replacement therapies in diseases associated with congenital absence or acquired loss of enteric neurons
CD90 liver cancer cells modulate endothelial cell phenotype through the release of exosomes containing H19 lncRNA priligy equivalent Our data provide a framework for exploring the molecular mechanisms that control enteric neurogenesis in vivo and identify glial cells as a potential target for cell replacement therapies in diseases associated with congenital absence or acquired loss of enteric neurons